ASCO update: hepatocellular and cholangiocellular carcinoma

SummaryAt ASCO 2022 several studies were presented. This short review is about hepatocellular carcinoma, and cholangiocellular carcinoma and trials like STAMP, ImmunoTACE trial, FOENIX-CCA2, ImmunoTACE trial, for example.

http://link.springer.com/10.1007/s12254-022-00845-2

Source: Memo - Magazine of European Medical Oncology - November 23, 2022 Category: Cancer & Oncology Source Type: research

More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver Cancer | Study